Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06682507

High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)

The goal of this observational study is to learn about the long-term renal and patient's survival of lupus nephritis (LN) patients in China. The main question it aims to answer is:

Does the renal and patient's survival improved in the long term period? Participants who had renal biopsy proven lupus nephritis in one hospital will be followed up.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Lupus Nephritis (LN) Autoimmune Diseases Chronic Disease Connective Tissue Diseases Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Glomerulonephritis Immune System Diseases Kidney Diseases Kidney Failure, Chronic Lupus Erythematosus, Systemic Lupus Nephritis Male Urogenital Diseases Nephritis Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Skin and Connective Tissue Diseases Urogenital Diseases Urologic Diseases

Age range

14 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Patients from 1996-2016 were retrospective enrolled and patients starting from 2017 were prespective enrolled

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients who had biopsy proven lupus nephritis in The First Affiliated Hospital of Sun Yat-sen University

Exclusion criteria

  • less than 14 years old
  • refused to give written consent

Treatment and study plan

No Intervention: Observational Cohort

Other

No Intervention: Observational Cohort

Primary outcomes

  1. Rate of patients with end stage renal disease

    Time frame: From data of enrollment until the data of first documented end stage renal disease, assessed up to 50 years

    End stage renal disease

Secondary outcomes

  1. Rate of patient's mortality

    Time frame: From data of enrollment until the data of death, assessed up to 50 years

    death

Study contacts

Contact information is provided by the study sponsor or research team.

Ruihan Tang, MD PHD

CONTACT

[email protected]

+8618998472466

Xi Xia, MD PHD

CONTACT

[email protected]

+8618825134511

Sponsors and collaborators

Lead sponsor

First Affiliated Hospital, Sun Yat-Sen University

Other

Registry information

Acronym: HOPE

Important dates

Study start
1996
Primary completion
2050
Study completion
2050
First posted
Nov 12, 2024
Registry last updated
Nov 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.